PerkinElmer Launches Comprehensive Solutions for Detecting SARS-CoV-2 Mutations

Company expands SARS-CoV-2 assay portfolio with RT-PCR and next generation sequencing solutions to identify mutations associated with SARS-CoV-2 variants WALTHAM, Mass.–(BUSINESS WIRE)–Mar. 9, 2021– PerkinElmer, Inc. (NYSE:PKI) today announced the launch of two Research Use Only (RUO) solutions, PKamp™ VariantDetect™ SARS-CoV-2 RT-PCR Assay and Next Generation Sequencing-based NEXTFLEX® Variant-Seq™ SARS-CoV-2 Kit. Using nucleic acid extracted... Read more

Luminex Receives FDA Emergency Use Authorization and CE Mark for Expanded NxTAG® Respiratory Panel Test Including SARS-CoV-2

Luminex® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry. Luminex Receives FDA Emergency Use Authorization and CE Mark for Expanded NxTAG® Respiratory Panel Test Including SARS-CoV-2 Mar 04, 2021 6:30 AM EST Provides labs with high throughput, syndromic respiratory testing capabilities AUSTIN, Texas, March 4, 2021... Read more

Live Cell Imaging to Study Neuron Development

Dr. Raman Das is an independent research fellow at the University of Manchester (United Kingdom). Using the chick embryo as a model organism, Dr. Das studies how cells develop into neurons and create the vertebrate central nervous system. In their recent publication, Dr. Das and his postdoctoral research associate, Dr. Gabriela Toro, used wide field... Read more

PerkinElmer Changes COVID-19 Rapid Testing Landscape with Highly Sensitive Point of Care Antigen Test for Mass Screening

Company expands portfolio of SARS-CoV-2 testing solutions with rapid antigen test benchmarked against gold standard RT-PCR WALTHAM, Mass.–(BUSINESS WIRE)–Feb. 23, 2021– PerkinElmer, Inc. (NYSE: PKI) today announced the launch of the PerkinElmer® COVID-19 Antigen Test for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigen in nasal (NS) or nasopharyngeal (NP) swab specimens. The lateral flow... Read more

Luminex Receives BARDA Funding to Support Development and Validation of Test Combining SARS-CoV-2 and Flu/RSV Respiratory Panel

Luminex® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry. Luminex Receives BARDA Funding to Support Development and Validation of Test Combining SARS-CoV-2 and Flu/RSV Respiratory Panel Feb 19, 2021 6:30 AM EST ARIES® Assay will simultaneously detect influenza A/B, RSV, and SARS-CoV-2 in a single test,... Read more

Thermo Fisher Scientific Acquires Leading Cell Sorting Technology from Propel Labs

Thermo Fisher Scientific Acquires Leading Cell Sorting Technology from Propel Labs WALTHAM, Mass., Feb. 17, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced it has acquired cell sorting technology assets from Propel Labs, a wholly-owned subsidiary of SIDIS Corp. Under the terms of the agreement, the recently... Read more

SPT Labtech acquires BioMicroLab

Deal strategically expands SPT Labtech’s offering in sample management for life sciences  To download this image, please click here. Cambridge, UK – 16 February 2021 – SPT Labtech, a global leader in the design and development of automated instrumentation and consumables for life science applications, announces the acquisition of BioMicroLab, a robotics automation provider for life science laboratories. Headquartered... Read more

PerkinElmer Launches First Cell Painting Kit

WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today launched the first cell painting kit as part of its new portfolio of PhenoVue™ cellular imaging reagents. This new range of reagents leverages PerkinElmer’s expertise in cellular imaging and high-content screening and works alongside the Company’s microplates, automation, software and industry-leading... Read more

FDA Grants Emergency Use Authorization for New COVID-19, Flu A, Flu B Combo Kit

One multiplex real-time PCR diagnostic kit can simultaneously detect and differentiate SARS-CoV-2, influenza A and influenza B CARLSBAD, Calif., Feb. 16, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for the Applied Biosystems TaqPath COVID-19, Flu A, Flu B Combo Kit from Thermo Fisher Scientific, the company announced... Read more